Funder
Iran National Science Foundation
Publisher
Public Library of Science (PLoS)
Reference149 articles.
1. Current trends in large cell lymphoma;RI Fisher;Leukemia,2003
2. VEGF Overexpression Is a Valuable Prognostic Factor for Non-Hodgkin’s Lymphoma Evidence from a Systemic Meta-Analysis;J Yang;Disease Markers,2015
3. Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: a non-randomised, phase 1b study;A Younes;Lancet Oncol,2014
4. Non-Hodgkin lymphoma;KR Shankland;Lancet,2012
5. Ifosfamide, carboplatin, etoposide (ICE)-based second-line chemotherapy for the management of relapsed and refractory aggressive non-Hodgkin's lymphoma;AD Zelenetz;Ann Oncol,2003
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献